Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02139852

Capsaicinoid Ingestion, Human Metabolism and Exercise

The Physiological Effects of Capsaicinoid Ingestion on Human Metabolism and Exercise Performance

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Prince Edward Island · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Capsaicinoids (the active ingredient in hot peppers) have been shown to cause a moderate increase in energy expenditure (50 kcal/day) as well as reductions in appetite, energy intake, and (visceral) adiposity. As such, there is considerable interest in capsaicinoid for weight loss supplements. Of particular interest are the recent findings that free-fatty acids in the blood are elevated 2-2.5hrs post ingestion, yet changes in typical cardiovascular or sympathetic nervous tone indicators (heart rate, blood pressure) were unaffected, suggesting some of the negative consequences of other stimulants may be avoided. At present, however, more in depth investigations of the effects on endothelial function, vascular autonomic tone and inflammation are lacking. The investigators seek to understand the effect of 3 months capsaicinoid ingestion on alterations in body composition, traditional cardiovascular risk factors and cardiovascular function Hypotheses: 1\) Continued use of capsaicinoids will alter resting metabolism substrate use, which will result in moderate (but clinically meaningful) alterations in body composition manifested as a decrease in adiposity. 2) Blood lipids will be unaffected by capsaicinoid use, as will brachial blood pressure. 3) Levels of systemic inflammation may increase slightly, and this could have an effect on vascular reactivity to hyperemic flow or baseline vascular tone. However, previous research suggests that these alterations will not be manifested in autonomic nervous tone assessed by changes in heart rate variability.

Detailed description

Project abandoned

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCapsaicin

Timeline

Start date
2014-06-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-05-15
Last updated
2022-06-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02139852. Inclusion in this directory is not an endorsement.